Heart failure in β-thalassemia syndromes: A decade of progress

American Journal of Medicine

Volumn 118, Issue 9, 2005, Pages 957-967

  Hahalis, George ^a,c   Alexopoulos, Dimitrios ^a   Kremastinos, Dimitrios T ^b   Zoumbos, Nicholas C ^a  

^a UNIVERSITY OF PATRAS   (Greece)

^b ONASSIS CARDIAC SURGERY CENTER   (Greece)

^c NONE   (Greece)

Author keywords

Cardiomyopathy; Chelation therapy; Heart failure; Iron overload; Thalassemia

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; ANTHRACYCLINE; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGITALIS GLYCOSIDE; DIURETIC AGENT; HEMOGLOBIN; HEMOGLOBIN E; IRON; VASODILATOR AGENT;

ANTICOAGULATION; ARTIFICIAL HEART PACEMAKER; BETA THALASSEMIA; BLOOD TRANSFUSION; CARDIAC RESYNCHRONIZATION THERAPY; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CAUSE OF DEATH; CHELATION THERAPY; CLINICAL FEATURE; DISEASE COURSE; ECHOCARDIOGRAPHY; GASTROINTESTINAL ABSORPTION; GENE THERAPY; HEART ATRIUM FIBRILLATION; HEART DISEASE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE; HEART VENTRICLE CONTRACTION; HEMATOLOGIC MALIGNANCY; HEMOGLOBIN SYNTHESIS; HEMOGLOBINOPATHY; HUMAN; IMMIGRATION; IMMOBILIZATION; INTRACARDIAC THROMBOSIS; IRON ABSORPTION; IRON OVERLOAD; MONOGENIC DISORDER; MYOCARDITIS; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; PULMONARY HYPERTENSION; REVIEW; SINUS RHYTHM; SURVIVAL; THALASSEMIA MAJOR; TISSUE INJURY;

BETA-THALASSEMIA; CHELATING AGENTS; HEART FAILURE, CONGESTIVE; HEMOGLOBIN E; HUMANS; HYPERTENSION, PULMONARY; IRON OVERLOAD; MYOCARDITIS; PERICARDITIS; VENTRICULAR DYSFUNCTION, LEFT;

EID: 24744453028     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjmed.2005.02.021     Document Type: Review

References (100)

1. D.J. Weatherall Thalassemia in the next millennium Ann N Y Acad Sci 850 1998 1 9
2. N.F. Olivieri The β-thalassemias N Engl J Med 341 1999 99 109 [Erratum, N Engl J Med. 1999;341:1407]
3. D.G. Nathan, R.B. Gunn Thalassemia the consequences of unbalanced hemoglobin synthesis Am J Med 41 1966 815 830
4. D.J. Weatherall, J.B. Clegg The β and δβ thalassemias in association with structural haemoglobin variants D.J. Weatherall J.B. Clegg The Thalassemia Syndromes 4th ed. 2001 Blackwell Scientific Publications Oxford, UK 393 449
5. A. Aessopos, D. Farmakis, M. Karagiorga Cardiac involvement in thalassemia intermedia a multicenter study Blood 97 2001 3411 3416
6. M.A. Engle, M. Erlandson, C.H. Smith Late cardiac complications of chronic, severe, refractory anemia with hemochromatosis Circulation 30 1964 698 705
7. W.L. Henry, A.W. Nienhuis, M. Wiener, D.R. Miller, W.C. Canale, S. Pionnelli Echocardiographic abnormalities in patients with tranfusion-dependent anemia and secondary myocardial iron deposition Am J Med 64 1978 547 560
8. G.M. Brittenham, P.M. Griffith, A.W. Nienhuis Efficacy of deferioxamine in preventing complications of iron overload in patients with thalassemia major N Engl J Med 331 1994 567 573
9. N.F. Olivieri, D.G. Nathan, J.H. MacMillan Survival in medically treated patients with homozygous β-thalassemia N Engl J Med 331 1994 574 578
10. D.T. Kremastinos, G.A. Tsetsos, D.P. Tsiapras, G.K. Karavolias, V.A. Ladis, C.A. Kattamis Heart failure in β-thalassemia a 5-year follow-up study Am J Med 111 2001 349 354
11. G. Hahalis, A.S. Manolis, I. Gerasimidou Right ventricular diastolic function in β-thalassemia major echocardiographic and clinical correlates Am Heart J 141 2001 428 434
12. G. Hahalis, A.S. Manolis, D. Apostolopoulos, D. Alexopoulos, A.G. Vagenakis, N.C. Zoumbos Right ventricular cardiomyopathy in β-thalassemia major Eur Heart J 23 2002 147 156
13. M.G. Zurlo, P. DeStefano, C. Borgna-Pignatti Survival and causes of death in thalassemia major Lancet 2 1989 27 30
14. B. Modell, M. Khan, M. Darlison Survival in β-thalassaemia major in the UK data from the UK thalassaemia register Lancet 355 2000 2051 2052
15. F. Lorey Asian immigration and public health in California thalassemia in newborns in California Pediatr Hematol Oncol 22 2000 564 566
16. J.M.C. Gutteridge, B. Halliwell Iron toxicity and oxygen radicals Baillieres Clin Haematol 2 1989 195 256
17. B.R. Bacon, C.H. Park, G. Brittenham, O', R. Neill, A.S. Tavill Hepatic mitochondrial oxidative metabolism in rats with chronic iron overload Hepatology 5 1985 789 797
18. C.A. Seymour, T.J. Peters Organelle pathology in primary and secondary hemochromatosis with special reference to lysosomal changes Br J Haematol 40 1978 239 253
19. G. Link, A. Athias, A. Grynberg, A. Pinson, C. Hershko Effect of iron loading on transmembrane potential, contraction, and automaticity of rat ventricular muscle cells in culture J Lab Clin Med 113 1989 103 111
20. G. Hahalis, A. Kalogeropoulos, A. Chrysanthopoulou Endothelial function is impaired and intina-media thickness of the common carotid arterial wall is increased in patients with β-thalassemia major (abstract) J Am Coll Cardiol 39 suppl A 2002 220A
21. M.A. Livrea, L. Tesoriere, A.M. Pintaudi Oxidative stress and antioxidant status in β-thalassemia major iron overload and depletion of lipid-soluble antioxidants Blood 88 1996 3608 3614
22. A. Nitenberg, F. Paycha, S. Ledoux, R. Sachs, J.R. Attali, P. Valensi Coronary artery responses to physiological stimuli are improved by deferoxamine but not by L-arginine in non-insulin-dependent diabetic patients with angiographically normal coronary arteries and no other risk factors Circulation 97 1998 736 743
23. L. Wolfe, N. Olivieri, D. Sallan Prevention of cardiac disease by subcutaneous deferoxamine in patients with thalassemia major N Engl J Med 312 1985 1600 1603
24. L.J. Anderson, M.A. Westwood, S. Holden Myocardial iron clearance with intravenous desferrioxamine a prospective study using T2* cardiovascular magnetic resonance Br J Haematol 127 2004 348 355
25. L.M. Buja, W.C. Roberts Iron in the heart. Etiology and clinical significance Am J Med 51 1971 209 221
26. P.F. Schellhammer, M.A. Engle, W.C. Hagstrom Histochemical studies of the myocardium and conduction system in acquired iron-storage disease Circulation 35 1967 631 637
27. K. Kyriakou, Y. Michailides, R. Senkus Ultrastructural pathology of the heart in patients with beta-thalassemia major Ultrastruct Pathol 24 2000 75 81
28. D. Sonakul, P. Pacharee, P. Wasi, S. Fucharoen Cardiac pathology in 47 patients with beta thlassemia/hemoglobin E Southeast Asian J Trop Med Public Health 15 1984 554 563
29. D. Sonakul, K. Thakerngpol, P. Pacharee Cardiac pathology in 76 thalassemic patients Birth Defects Orig Artic Ser 23 1988 177 191
30. S. Fucharoen, P. Winichagoon Hemoglobinopathies in Southeast Asia molecular biology and clinical medicine Hemoglobin 21 1997 299 319
31. D. Sonakul, P. Pacharee, T. Laohapand, S. Fucharoen, P. Wasi Pulmonary artery obstruction in thalassemia Southeast Asian J Trop Med Public Health 11 1981 516 523
32. M. Humbert, O. Sitbon, Simonneau Treatment of pulmonary arterial hypertension N Engl J Med 351 2004 1425 1436
33. D.H. Fitchett, D.J. Coltart, W.A. Littler Cardiac involvement in secondary hemochromatosis a catheter biopsy study and analysis of myocardium Cardiovasc Res 14 1980 719 724
34. D.T. Kremastinos, G. Tiniakos, G.N. Theodorakis, D.G. Katritsis, P.K. Toutouzas Myocarditis in β-thalassemia major. A cause of heart failure Circulation 91 1995 66 71
35. E. Economou-Petersen, A. Aessopos, A. Kladi Apolipoprotein E ε4 allele as a genetic risk factor for left ventricular failure in homozygous β-thalassemia Blood 92 1998 3455 3459
36. M. Jessup, C.S. Manno Diagnosis and management of iron-induced heart disease in Cooley's anemia Ann N Y Acad Sci 850 1998 242 250
37. I.S. Anand, Y. Chandrashekhar, R. Ferrari, P.A. Poole-Wilson, P.C. Harris Pathogenesis of oedema in chronic severe anaemia studies of body water and sodium, renal function, haemodynamic variables, and plasma hormones Br Heart J 70 1993 352 356
38. B. Salsaa, N.C. Zoumbos A distinct pattern of cytokine production from blood mononuclear cells in multitransfused patients with β-thalassemia Clin Exp Immunol 107 1997 589 592
39. D.S. Kyriakou, M.G. Alexandrakis, E.S. Kyriakou Activated peripheral blood and endothelial cells in thalassemia patients Ann Hematol 8 2001 577 583
40. A. Matsumori, Y. Matoba, S. Sasayama Dilated cardiomyopathy associated with hepatitis C virus infection Circulation 92 1995 2519 2525
41. Y.F. Cheung, G.C. Chan, S.Y. Ha Arterial stiffness and endothelial function in patients with beta-thalassemia major Circulation 106 2002 2561 2566
42. G.L. Forni, G. Derchi Typical manifestation of acute congestive heart failure in patients with thalassaemia major causing diagnostic delay in the emergency room Eur J Heart Fail 5 2003 607 608
43. M.A. Engle Cardiac involvement in Cooley's anemia Ann N Y Acad Sci 119 1969 694 702
44. Z.G. Fridlender, D. Rund Myocardial infarction in a patient with β-thalassemia major first report Am J Hematol 75 2004 52 55
45. D.T. Kremastinos, P. Flevari, M. Spyropoulou Association of heart failure in homozygous beta-thalassemia with the major histocompatibility complex Circulation 100 1999 2074 2078
46. P. Richardson, W. McKenna, M. Bristow Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies Circulation 93 1996 841 842
47. Du Zhong-Dong, N. Roguin, E. Milgram, K. Saab, A. Koren Pulmonary hypertension in patients with thalassemia major Am Heart J 134 1997 532 537
48. D. Grisaru, E.A. Rachmilewitz, M. Mosseri Cardiopulmonary assessment in beta-thalassemia major Chest 98 1990 138 142
49. T. Hovav, A. Goldfare, G. Artman Enhanced adherence of β-thalassemic erythrocytes to endothelial cells Br J Haematol 106 1999 178 181
50. A. Aessopos, D. Farmakis, D. Loukopoulos Elastic tissue abnormalities resembling pseudoxanthoma elasticum in beta thalassemia and the sickling syndromes Blood 99 2002 30 35
51. J.M. Factor, S.R. Pottipati, I. Rappoport, I.K. Rosner, M.L. Lessser, P.J. Giardina Pulmonary function abnormalities in thalassemia major and the role of iron overload Am J Respir Crit Care Med 149 1994 1570 1574
52. A. Eldor, E.A. Rachmilewitz The hypercoagulable state in thalassemia Blood 99 2002 36 43
53. D.T. Kremastinos, D.P. Tsiapras, G.A. Tsetsos, E.I. Rentoukas, H.P. Vretou, P.K. Toutouzas Left ventricular diastolic Doppler characteristics in β-thalassemia major Circulation 88 1993 1127 1135
54. P. Spirito, G. Lupi, C. Melevendi, C. Vecchio Restrictive diastolic abnormalities identified by Doppler echocardiography in patients with thalassemia major Circulation 82 1990 88 94
55. V.K. Bahl, O.P. Malhotra, D. Kumar Noninvasive assessment of systolic and diastolic left ventricular function in patients with chronic severe anemia a combined M-mode, two-dimensional and Doppler echocardiographic study Am Heart J 124 1992 1516 1523
56. D.T. Kremastinos, E. Rentoukas, S. Mavrogenis Left ventricular filling pattern in β-thalassaemia major-a Doppler echocardiographic study Eur Heart J 14 1993 351 357
57. M.T. Gladwin, V. Sachdev, M.L. Jison Pulmonary hypertension as a risk factor for death in patients with sickle cell disease N Engl J Med 350 2004 886 895
58. D.J. Weatherall, J.B. Clegg The β thalassemias D.J. Weatherall J.B. Clegg The Thalassemia Syndromes 4th ed. 2001 Blackwell Scientific Publications Oxford, UK 287 356
59. S. Fucharoen, P. Ketvichit, P. Pootrakul Clinical manifestation of beta-thalassemia/hemoglobin E disease J Pediatr Hematol Oncol 22 2000 552 557
60. D. Sonakul, S. Furcharoen Pulmonary thromboembolism in thalassemic patients Southeast Asian J Trop Med Public Health 23 suppl 2 1992 25 28
61. P. Jootar, S. Fucharoen Cardiac involvement in beta-thalassemia/ hemoglobin E disease clinical and hemodynamic findings Southeast Asian J Trop Med Public Health 21 1990 269 273
62. V. Atichartakarn, K. Likittanasombat, S. Chuncharunee Pulmonary arterial hypertension in previously splenectomized patients with β-thalassemic disorders Int J Hematol 78 2003 139 145
63. P. Butthep, S. Rummavas, R. Wisedpanichkij Increased circulating activated endothelial cells, vascular endothelial growth factor, and tumor necrosis factor in thalassemia Am J Hematol 70 2002 100 106
64. M. Vaccari, R. Crepaz, M. Fortini Left ventricular remodeling, systolic function, and diastolic function in young adults with β-thalassemia intermedia Chest 121 2002 506 512
65. A.W. Nienhuis, P. Griffith, H. Strawczynski Evaluation of cardiac function in patients with thalassemia major Ann N Y Acad Sci 344 1980 384 396
66. D.T. Kremastinos, P.K. Toutouzas, G.P. Vyssoulis, C.A. Venetis, H.P. Vretou, D.G. Avgoustakis Global and segmental left ventricular function in β-thalassemia Cardiology 72 1985 129 139
67. K.C. Lau, M.C. Li, P.W. Hui, C.Y. Yeung Left ventricular function in β thalassemia major Arch Dis Child 64 1989 1046 1051
68. K.M. Borow, R. Propper, F.Z. Bierman, S. Grady, A. Inati The left ventricular end-systolic pressure-dimension relation in patients with thalassemia major Circulation 66 1982 980 985
69. E. Mariotti, A. Agostini, E. Angellucci, G. Lucarelli, E. Sgarbi, E. Picano Reduced left ventricular contractile reserve identified by low dose dobutamine echocardiography as an early marker of cardiac involvement in asymptomatic patients with thalassemia major Echocardiography 13 1996 463 472
70. M. Vogel, L.J. Anderson, S. Holden Tissue Doppler echocardiography in patients with thalassaemia detects early myocardial dysfunction related to myocardial iron overload Eur Heart J 24 2003 113 119
71. A.P. Freeman, R.W. Giles, V.A. Berdoukas, W.F. Walsh, D. Choy, P.C. Murray Early left ventricular dysfunction and chelation therapy in thalassemia major Ann Intern Med 99 1983 450 454
72. F. Lattanzi, P. Bellotti, E. Picano Quantitative ultrasonic analysis of myocardium in patients with thalassemia major and iron overload Circulation 87 1993 748 754
73. E. Angelucci, G.M. Brittenham, C.E. McLaren Hepatic iron concentration and total body iron stores in thalassemia major N Engl J Med 343 2000 327 331
74. G.M. Brittenham, D.E. Farrell, J.W. Harris Magnetic-susceptibility measurement of human iron stores N Engl J Med 307 1982 1671 1675
75. D.L. Johnston, L. Rice, G.W. Vick III Assessment of tissue iron overload by nuclear magnetic resonance imaging Am J Med 87 1989 40 47
76. L. Anderson, S. Holden, B. Davis Cardiovascular T2-star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload Eur Heart J 22 2001 2171 2179
77. G.M. Brittenham, A.R. Cohen, C.E. McLaren Hepatic iron stores and plasma ferritin concentration in patients with sickle cell anemia and thalassemia major Am J Hematol 42 1993 81 85
78. G. Fiorelli, S. Fargion, A. Piperno, N. Battafarano, M.D. Cappellini Iron metabolism in thalassemia intermedia Haematologica 75 Suppl 5 1990 89 95
79. E. Voskaridou, M. Douskou, E. Terpos Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassemia and sickle cell disease Br J Haematol 126 2004 736 742
80. C. Borgna-Pignatti, S. Rugolotto, P. De Stefano Survival and disease complications in thalassemia major Ann N Y Acad Sci 850 1998 227 231
81. A. Aessopos, D. Farmakis, A. Hatziliami Cardiac status in well-treated patients with thalassemia major Eur J Haematol 73 2004 359 366
82. K.R. Laurita, E.T. Chuck, T. Yang Optical mapping reveals conduction slowing and impulse block in iron-overload cardiomyopathy J Lab Clin Med 142 2003 83 89
83. B. Modell, E.A. Letsky, D.M. Flynn, R. Peto, D.J. Weatherall Survival and desferrioxamine in thalassemia major Br Med J 284 1982 1081 1084
84. K.H. Ehlers, P.J. Giardina, M.L. Lesser, M.A. Engle, M.W. Hilgartner Prolonged survival in patients with beta-thalassemia major treated with deferoxamine J Pediatr 118 1994 540 545
85. B.A. Davis, J.B. Porter Long-term outcome of continuous 24-hour deferoxamine infusion via indwelling intravenous catheters in high-risk β-thalassemia Blood 95 2000 1229 1236
86. G.M. Felker, R.E. Thompson, J.M. Hare Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy N Engl J Med 342 2000 1077 1084
87. The SOLVD investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fraction and congestive heart failure N Engl J Med 325 1991 293 302
88. H. Miskin, I. Yaniv, M. Berant Reversal of cardiac complications in thalassemia major by long-term intermittent daily intensive iron chelation Eur J Haematol 70 2003 398 403
89. S.A. Hunt, D.W. Baker, M.H. Chin ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: executive summary. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines J Am Coll Cardiol 38 2001 2101 2113
90. H.I. Karvounis, T.A. Zaglavara, G.E. Parcharidis An angiotensin- converting enzyme inhibitor improves left ventricular systolic and diastolic function in transfusion-dependent patients with beta-thalassemia major Am Heart J 141 2001 2817
91. B.A. Davis, C. O'Sullivan, P.H. Jarritt, J.B. Porter Value of sequential monitoring of left ventricular ejection fraction in the management of thalassemia major Blood 104 2004 263 269
92. G. Link, R. Tirosh, A. Pinson, C. Hershko Role of iron in the potentiation of anthracycline cardiotoxicity identification of heart mitochondria as a major site of iron-anthracycline interaction J Lab Clin Med 127 1996 272 278
93. W.T. Abraham, D.L. Hayes Cardiac resynchronization therapy for heart failure Circulation 108 2003 2596 2603
94. M.M. Koerner, G. Tenderlich, K. Minami Heart transplantation for end-stage heart failure caused by iron overload Br J Haematol 97 1997 293 296
95. N.F. Olivieri, S. De Silva, A. Premawardena Iron overload and iron-chelating therapy in hemoglobin E-beta thalassemia J Pediatr Hematol Oncol 22 2000 593 597
96. K.H. Wu, J.S. Chang, C.H. Tsai, C.T. Peng Combined therapy with deferiprone and desferrioxamine successfully regresses severe heart failure in patients with beta-thalassemia major Ann Hematol 83 2004 471 473
97. V. Atichartakarn, S. Chuncharunee, P. Chandanamattha Correction of hypercoagulability and amelioration of pulmonary arterial hypertension by chronic blood transfusion in an asplenic hemoglobin E/beta-thalassemia patient Blood 103 2004 2844 2846
98. L.J. Anderson, B. Wonke, E. Prescott Comparison of effects of oral deferiprone and subcutaneous desferrioxamine on myocardial iron concentrations and ventricular function in beta-thalassaemia Lancet 360 2002 516 520
99. P. Pootrakul, P. Sirankapracha, J. Sankote Clinical trial of deferiprone iron chelation therapy in beta-thalassaemia/haemoglobin E patients in Thailand Br J Haematol 122 2003 305 310
100. A.W. Nienhuis, H. Hanawa, N. Sawai Development of gene therapy for hemoglobin disorders Ann N Y Acad Sci 996 2003 101 111